ESTRO 2025 - Abstract Book

S3605

Physics - Quality assurance and auditing

ESTRO 2025

Keywords: Radiotherapy, Dose-escalation, Dummy-run

References: 1. Gronberg, B.H., et al., High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet Oncol, 2021. 22 (3): p. 321-331.

1234

Poster Discussion Radiotherapy quality assurance in PROTECT – a European randomised phase III-trial comparing proton and photon therapy in oesophageal cancer patients. Camilla S Byskov 1 , Hanna R Mortensen 1,2 , Rebecca Bütof 3,4 , Richard Canters 5 , Gilles Defraene 6 , Mai L Ehmsen 2 , Karin Haustermans 6,7 , Sarah E Jensen 2 , Maria F Jensen 2 , Arturs Meijers 8 , Christina T Muijs 9 , Ditte S Møller 1,10 , Marianne Nordsmark 1 , Pieter Populaire 6,7 , Muhammad Shamshad 11 , Gloria Vilches-Freixas 5 , Lone Hoffmann 1,10 1 Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark. 2 Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus N, Denmark. 3 Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden, Germany. 4 OncoRay – National Center for Radiation